Tekla Life Sciences Investors (HQL) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Tekla Life Sciences Investors (HQL) quarterly cash flow statement — complete operating, investing & financing history

Metric	Q2'26	Q4'25	Q2'25	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21	Q2'21	Q4'20	Q2'20	Q4'19	Q2'19	Q4'18	Q2'18	Q4'17	Q2'17	Q4'16	Q2'16	Q4'15

Cash from Operations	-1.22M	-1.28M	-1.04M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-45.81K
Operating CF Margin %	-2.54%	-10.96%	-5.74%	-	-	-	-	0%	0%	-	-	0%	0%	-	-	-	-	-	-	-5487.52%
Operating CF Growth %	-16.71%	-	-	-	-	100%	100%	-	-	100%	100%	-	-	-	-	-	-	100%	-100%	21.84%
Net Income	65.34M	132.83M	-47.23M	11.18M	33.8M	-52.3K	-52.3K	32.27K	32.27K	61.53K	61.53K	-35.24K	-35.24K	14.33K	14.33K	34.28K	34.28K	-5.96K	-5.96K	-50.55K
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-66.7M	-133.97M	46.26M	-11.18M	-33.8M	52.3K	52.3K	-32.27K	-32.27K	-61.53K	-61.53K	35.24K	35.24K	-14.33K	-14.33K	-34.28K	-34.28K	5.96K	5.96K	5.14K
Working Capital Changes	139.03K	-129.61K	-73.8K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-401
Change in Receivables	-15.68K	182.5K	-123.27K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	15.28K	-15.28K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	10.17M	20.83M	4.39M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	0%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments	561.89M	514.12M	12.16M	412.77M	432.64M	414.08M	444.99M	534.01M	503.2M	483.97M	397.21M	381.47M	420.08M	466.45M	436.9M	436.87M	382.21M	370.84M	337.72M	443.83M
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	-16.6M	-23.22M	-8.41M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.07K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	-18.17M	-31.63M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.07K
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	1.57M	8.41M	-8.41M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	-75.54K	75.54K	0	32	377	-545	-545	-1	-1	0	0	1.12M	1.12M	0	0	0	0	0	0	-17.87K
Free Cash Flow	-1.22M	-1.28M	-1.04M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-45.81K
FCF Margin %	-2.54%	-10.96%	-5.74%	-	-	-	-	0%	0%	-	-	0%	0%	-	-	-	-	-	-	-5487.52%
FCF Growth %	-16.71%	-	-	-	-	100%	100%	-	-	100%	100%	-	-	-	-	-	-	100%	-100%	21.84%
FCF per Share	-0.04	-0.04	-0.04	-	-	-	-	0.00	0.00	-	-	0.00	0.00	-	-	-	-	-	-	-2.33
FCF Conversion (FCF/Net Income)	-0.02x	-0.01x	0.02x	-	-	-	-	0.00x	0.00x	-	-	0.00x	0.00x	-	-	-	-	-	-	0.91x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Tekla Life Sciences Investors (HQL) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Tekla Life Sciences Investors (HQL) quarterly cash flow statement — complete operating, investing & financing history

Annual Quarterly

Metric	Q2'26	Q4'25	Q2'25	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21	Q2'21	Q4'20	Q2'20	Q4'19	Q2'19	Q4'18	Q2'18	Q4'17	Q2'17	Q4'16	Q2'16	Q4'15

Cash from Operations	-1.22M	-1.28M	-1.04M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-45.81K
Operating CF Margin %	-2.54%	-10.96%	-5.74%	-	-	-	-	0%	0%	-	-	0%	0%	-	-	-	-	-	-	-5487.52%
Operating CF Growth %	-16.71%	-	-	-	-	100%	100%	-	-	100%	100%	-	-	-	-	-	-	100%	-100%	21.84%
Net Income	65.34M	132.83M	-47.23M	11.18M	33.8M	-52.3K	-52.3K	32.27K	32.27K	61.53K	61.53K	-35.24K	-35.24K	14.33K	14.33K	34.28K	34.28K	-5.96K	-5.96K	-50.55K
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-66.7M	-133.97M	46.26M	-11.18M	-33.8M	52.3K	52.3K	-32.27K	-32.27K	-61.53K	-61.53K	35.24K	35.24K	-14.33K	-14.33K	-34.28K	-34.28K	5.96K	5.96K	5.14K
Working Capital Changes	139.03K	-129.61K	-73.8K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-401
Change in Receivables	-15.68K	182.5K	-123.27K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	15.28K	-15.28K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	10.17M	20.83M	4.39M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	0%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments	561.89M	514.12M	12.16M	412.77M	432.64M	414.08M	444.99M	534.01M	503.2M	483.97M	397.21M	381.47M	420.08M	466.45M	436.9M	436.87M	382.21M	370.84M	337.72M	443.83M
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	-16.6M	-23.22M	-8.41M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.07K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	-18.17M	-31.63M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.07K
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	1.57M	8.41M	-8.41M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	-75.54K	75.54K	0	32	377	-545	-545	-1	-1	0	0	1.12M	1.12M	0	0	0	0	0	0	-17.87K
Free Cash Flow	-1.22M	-1.28M	-1.04M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-45.81K
FCF Margin %	-2.54%	-10.96%	-5.74%	-	-	-	-	0%	0%	-	-	0%	0%	-	-	-	-	-	-	-5487.52%
FCF Growth %	-16.71%	-	-	-	-	100%	100%	-	-	100%	100%	-	-	-	-	-	-	100%	-100%	21.84%
FCF per Share	-0.04	-0.04	-0.04	-	-	-	-	0.00	0.00	-	-	0.00	0.00	-	-	-	-	-	-	-2.33
FCF Conversion (FCF/Net Income)	-0.02x	-0.01x	0.02x	-	-	-	-	0.00x	0.00x	-	-	0.00x	0.00x	-	-	-	-	-	-	0.91x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

HQL Cash Flow Statement

HQL Cash Flow Statement